DMC and Hospital, Ludhiana Report issue

Academic/Hospital Phase 4

Organization Overview

First Clinical Trial
2013
NCT01722578
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2013

Timeline

NOW
  • Now

Alternative names

Professor, Dept of Gastroenterology, DMC and Hospital, Ludhiana, India

Active Ingredients

Drugs in Phase 4 Trials (1)

ornithine aspartate (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Brain Diseases (Phase 4)

Fibrosis (Phase 4)

Hepatic Encephalopathy (Phase 4)

Liver Cirrhosis (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 1
  • # of Trial APIs: 1